Legacy Financial Advisors, Inc. Takeda Pharmaceutical CO LTD Transaction History

Legacy Financial Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.6 - $13.67 $34,183 - $37,086	-2,713 Reduced 10.71%	22,620 $292,000
Q1 2024 May 14, 2024	BUY	$13.89 - $15.04 $8,278 - $8,963	596 Added 2.41%	25,333 $351,000
Q4 2023 Feb 06, 2024	SELL	$13.36 - $15.43 $10,848 - $12,529	-812 Reduced 3.18%	24,737 $352,000
Q3 2023 Nov 13, 2023	BUY	$15.03 - $16.32 $12,535 - $13,610	834 Added 3.37%	25,549 $395,000
Q2 2023 Aug 08, 2023	BUY	$15.57 - $17.11 $5,636 - $6,193	362 Added 1.49%	24,715 $388,000
Q1 2023 May 03, 2023	BUY	$15.28 - $16.48 $13,156 - $14,189	861 Added 3.67%	24,353 $401,000
Q4 2022 Feb 06, 2023	SELL	$12.42 - $15.62 $76,283 - $95,938	-6,142 Reduced 20.73%	23,492 $366,000
Q3 2022 Nov 09, 2022	BUY	$12.8 - $28.65 $118,579 - $265,413	9,264 Added 45.48%	29,634 $384,000
Q2 2022 Aug 08, 2022	BUY	$13.12 - $15.03 $223 - $255	17 Added 0.08%	20,370 $286,000
Q1 2022 May 04, 2022	BUY	$13.54 - $15.35 $275,579 - $312,418	20,353 New	20,353 $291,000
Q2 2019 Aug 07, 2019	SELL	$16.58 - $20.49 $4,973 - $6,146	-300 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $5,010 - $6,456	300 New	300 $6,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Legacy Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Legacy Financial Advisors, Inc. with notifications on news.